Asclepion Laser Technologies GmbH

The company took a leading role in 1984 with the introduction of the argon laser for the treatment of vascular lesions of the retina. This was followed by the development of the MCL29 Dermablate, the first erbium laser for dermatological applications. Asclepion’s areas of expertise include dermatology, surgery, gynecology, general medicine and urology. The company is headquartered in Jena, one of the most important centers of the optics industry.
Facts
- Established: 1977
- Industries: Medical technology and life sciences
- Employees: 160
- Annual turnover: €60m
- Represented in more than 70 countries
Contact
Asclepion Laser Technologies GmbH
Brüsseler Str. 10
07747 Jena
+49 3641 7700-100
https://www.asclepion.com